{
  "id": 560694,
  "title": "Vaderis gets $152M to run Phase 3 of rare bleeding disorder treatment",
  "url": "https://urgent.news/2026/08/11/vaderis-gets-152m-to-run-phase-3-of-rare-bleeding-disorder-treatment",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-11T11:00:15.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/vaderis-gets-152m-to-run-phase-3-of-rare-bleeding-disorder-treatment/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Vaderis Therapeutics’ bet that a type of treatment developed for cancers could work for a rare blood disorder is paying off. The 13-person Swiss startup raised $152 million in a Series B to run a ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}